Page 2 - Sun Pharmaceutical Industries Ltd News

Ajit Mishra recommends buy on Aether Energy, Sun Pharma; sell on ITC

Ajit Mishra of Religare Broking says that Ather Energy and Sun Pharma have a given a upside breakout after a period of consolidation, while ITC seems to be losing momentum on charts.

Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why

Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.

Stocks to Watch today: Maruti, RCF, BHEL, Torrent Pharma, Tata Power, IHCL

Stocks to watch today: Maruti Suzuki, Uno Minda, BHEL, Torrent Pharma, Tata Power, IHCL, IDFC First Bank, Kalyan Jewellers, Premier Energies, RCF, RRP Defense, among others, will be in focus today

SBI joins global banks to fund Sun Pharma's $11.75 billion Organon buy

SBI is the only domestic bank to participate in the loan syndication

Nifty Pharma rallies 2%; Laurus, Ipca, Aurobindo, Torrent hit record highs

In the past month, the Nifty Pharma index outperformed the market by surging 7.4 per cent, as compared to 4.2 per cent rise in the Nifty 50.

Dividend stocks: Mphasis, Titan, Nestle, 41 others go ex-date next week

Dividend stocks: Here is the complete list of stocks that will remain in focus next week on account of their dividend announcements

Nifty Pharma index up 2%; Dr Reddy's, Ajanta, Ipca, Cipla surge up to 5%

In the past seven trading days, the Nifty Pharma index outperformed the market by soaring 5.4 per cent, as compared to 0.1 per cent decline in the Nifty 50.

Sun Pharma to acquire 100% stake in Innovcare Lifesciences for $28.7 mn

Sun ​Pharmaceutical Industries said ‌it will acquire 100% of ​Innovcare Lifesciences

Patent expiry: A $5 bn opportunity for Indian pharma majors, says report

Lupin, Intas Pharmaceuticals, Sun Pharma, MSN Laboratories, Natco Pharma, Zydus Life Sciences and Dr Reddy's Laboratories are some of the companies, the note said, that could potentially benefit.

India's pharma market gets a lift from rising volumes, not just prices

Chronic therapies and GLP-1 adoption help broaden growth drivers as the market expands over 10 per cent in April and May

Sun Pharma's Unloxcyt posts 50% response rate in skin cancer study

Updated data from the CK-301-101 trial showed durable responses and manageable safety profile in patients with locally advanced cutaneous squamous cell carcinoma

Sun Pharma shares slip post Q4; analysts cautious on near-term upside

In the March quarter, Sun Pharma reported net profit at ₹2,714 crore, as compared to ₹2,150 crore a year ago, up 26.2 per cent year-on-year (Y-o-Y)

Sun Pharma's US generics business remains under pressure in FY26

Innovative medicines business crosses $1 billion milestone as company expands specialty pipeline and bets on Organon acquisition

Sun Pharma posts Q4 profit of ₹2,714 crore on strong specialty drug demand

India's largest drugmaker reported stronger-than-expected quarterly profit as growth in specialty medicines offset weakness in US sales

Q4 results: Sun Pharma, Eicher Motors, and Colgate among 187 on May 22

Q4FY26 company results: Firms including Hindalco Industries, Fortis Healthcare, Torrent Pharmaceuticals, Info Edge (India), and TTK Prestige are also to release their January-March earnings today

Why pharma stocks are emerging as safe bet amid global market turmoil

The pharma sector is seen as a safe bet because demand remains steady even during inflation or economic slowdowns. Besides, companies earn revenue from multiple global markets, which helps reduce risk

Organon deal impact: Sun Pharma surges 16% in 10 days, nears record high

Sun Pharma's acquisition of Organon as a transformational deal, doubling revenue to USD 12 billion with 30 per cent EBITDA margin, analysts.

Nifty Pharma hits 52-wk high; Wockhardt up 15%, Laurus, Lupin at new peaks

The Nifty Pharma index was quoting higher for the fifth straight trading day, surging 3.8 per cent during the period, as against 0.37 per cent gain in Nifty 50.

Analyst suggests 'Bull Spread' on Midcap Nifty, Sun Pharma; check strategy

Nandish Shah of HDFC Securities has shared Bull Spread' on strategy on Midcap Nifty and Sun Pharma

Sun Pharma exploring Eurobonds, bond swaps to fund US-based Organon buy

According to bankers, the Indian pharma major plans to raise around $10 billion from various sources, while the remaining will be funded through internal accruals